I had another read of this quarterly last night and I feel much better with the company's prospects after a second, more detailed read. The accounts on face value are a bit messy with the Thor acquisition, but looking past that, underlying revenue growth for the 1A was brilliant, and it bodes well with BP+ and Spiro about to launch next month.
I'm not sure if it is a trend or not, but the last two 2Q have been strong ones for UCM, so if it is a seasonal thing for medical device purchases then there could be a great chance to build on the momentum of the growth in this quarterly.
The price has had a steady ride from the 13c lows, but there appears to be a lot of value still left in this one. I don't have the same conviction that I do in some other stocks, and honestly it stems from the lack of faith in management. Without disparaging Rob and other directors, they have over-promised and under-delivered in the past, and there have been a few "false starts" with revenue growth as well.
This does seem like the best opportunity the company has had to really take off since I have been looking at it though, and I am really bullish on the integration benefits of Thor, particularly for manufacturing and distribution.
I sold down some holdings in UCM a while back, but the current SP is around my original purchase price and the company has evolved a lot since then. I will certainly look to top up if the opportunity arises.
- Forums
- ASX - By Stock
- Ann: Appendix 4C - quarterly
UCM
uscom limited
Add to My Watchlist
0.00%
!
1.6¢

I had another read of this quarterly last night and I feel much...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.007M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.6¢ | $1.573K | 98.31K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 74999 | 1.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 200000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 74999 | 0.016 |
1 | 300000 | 0.013 |
1 | 132270 | 0.012 |
1 | 46000 | 0.011 |
3 | 1100000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 200000 | 1 |
0.019 | 46000 | 1 |
0.021 | 24866 | 1 |
0.055 | 10083 | 1 |
0.100 | 57758 | 1 |
Last trade - 15.26pm 04/07/2025 (20 minute delay) ? |
Featured News
UCM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online